HANNA SUMMERS: Open Payments
NPI 1538700216 · RICHMOND, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,255 in 51 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $347 · 2025 $1,255
Food & beverage: $1,255
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $622 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $182 |
| Janssen Biotech, Inc. | 3 | $116 |
| Madrigal Pharmaceuticals | 1 | $96 |
| Ardelyx, Inc. | 5 | $84 |
| Novo Nordisk Inc | 2 | $41 |
| Enterra Medical, Inc. | 1 | $28 |
| Intercept Pharmaceuticals, Inc. | 1 | $21 |
| Ipsen Biopharmaceuticals, Inc | 1 | $19 |
| PFIZER INC. | 1 | $17 |
Products named: SKYRIZI, RINVOQ, TREMFYA, ENTYVIO, REZDIFFRA, IBSRELA, EOHILIA, Wegovy.
Industry payments across VA — which companies pay providers there.
